Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 12 Projects
Project # Contact PI Funding Organization Fiscal Year
Evaluating the effects of GLP-1 analog, oral semaglutide, as a treatment for sporadic behavioral variant frontotemporal dementia (bvFTD)
ADDF-33 Edison, Paul Alzheimer's Drug Discovery Foundation 2021
A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform
ADDF-13 Ballard, Clive Alzheimer's Drug Discovery Foundation 2020
Inflammatory Markers for Early Detection & Subtyping of Neurodegenerative & Mood Disorders
GC-201712-2014401 Upton, Meredith Alzheimer's Drug Discovery Foundation 2018
4th Annual Goodes Prize for Excellence in Alzheimer’s Drug Discovery: Imaging Sub-study for the HOPE4MCI Phase 3 Trial
GC-201808-2016199 GALLAGHER, MICHELA Alzheimer's Drug Discovery Foundation 2018
Amyloid beta proteins as biomarkers of AMD: insights into common disease mechanisms in the senescent retina and brain
ARUK-FFS2018-02 J. Arjuna Ratnayaka Alzheimer's Research UK 2018
Identification of novel biofluid markers of TDP-43 pathology
ARUK-CRF2017B-2 Rachelle Shafei Alzheimer's Research UK 2017
Accelerating Manufacture of Clinical Supplies for Initiation of Patient Enrollment in the HOPE4MCI Phase 3 Trial (AgeneBio, AGB101)
GC-2013118 ROSENZWEIG-LIPSON, SHARON Alzheimer's Drug Discovery Foundation 2016
Reduced Regional Cortical Thickness Rate of Change in Donepezil Treated Subjects with Suspected Prodromal Alzheimer’s Disease – a Longitudinal Multi-Centric Double-Blind, Randomized, Placebo-Controlled Trial
V1504 Enrica CAVEDO Fondation Vaincre Alzheimer (France) 2015
The utility of measuring plasma phosphorylated alpha-synuclein levels as a biomarker for Dementia with Lewy bodies
ARUK-NCG2013A-4 Allsop, David Alzheimer's Research UK 2013
Biomarker Optimization for Progranulin Trials
20111104 AFTD-Boxer-2011 BOXER, ADAM L Alzheimer's Drug Discovery Foundation 2011